Transcription of HERV-E and HERV-E-related sequences in malignant and non-malignant human haematopoietic cells

Virology

Volumn 382, Issue 1, 2008, Pages 37-45

  Prusty, Bhupesh K ^a   zur Hausen, Harald ^a   Schmidt, Rainer ^a   Kimmel, Romana ^a   de Villiers, Ethel Michele ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

env; gag; Haematopoietic malignancies; HERV E; pol

Indexed keywords

GAG PROTEIN;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 8P; CONTROLLED STUDY; ENVELOPE GENE; GEL ELECTROPHORESIS; GENE INSERTION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN ENDOGENOUS RETROVIRUS E POLYMERASE GENE; HUMAN GENOME; MYELOID LEUKEMIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURAL GENE;

BLOOD CELLS; CELL LINE; CELL LINE, TUMOR; ENDOGENOUS RETROVIRUSES; GENE EXPRESSION PROFILING; GENES, VIRAL; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; TRANSCRIPTION, GENETIC;

HUMAN ENDOGENOUS RETROVIRUS; HUMAN HERPESVIRUS 6;

EID: 55249090365     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.09.006     Document Type: Article

References (62)

1. Armbruester V., Sauter M., Krautkraemer E., Meese E., Kleiman A., Best B., Roemer K., and Mueller-Lantzsch N. A novel gene from the human endogenous retrovirus K expressed in transformed cells. Clin. Cancer Res. 8 (2002) 1800-1807
2. Bannert N., and Kurth R. Retroelements and the human genome: New perspectives on an old relation. Proc. Natl. Acad. Sci. USA 101 (2004) 14572-14579
3. Belshaw R., Watson J., Katzourakis A., Howe A., Woolven-Allen J., Burt A., and Tristem M. Rate of recombinational deletion among human endogenous retroviruses. J. Virol. 81 (2007) 9437-9442
4. Bessis D., Molès J.P., Basset-Séguin N., Tesniere A., Arpin C., and Guilhou J.J. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin. Br. J. Dermatol. 151 (2004) 737-745
5. Bieda K., Hoffmann A., and Boller K. Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines. J. Gen. Virol. 82 (2001) 591-596
6. Blond J.L., Besème F., Duret L., Bouton O., Bedin F., Perron H., Mandrand B., and Mallet F. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J. Virol. 73 (1999) 1175-1185
7. Boese A., Sauter M., Galli U., Best B., Herbst H., Mayer J., Kremmer E., Roemer K., and Mueller-Lantzsch N. Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein. Oncogene 19 (2000) 4328-4336
8. Brodsky I., Foley B., Haines D., Johnston J., Cuddy K., and Gillespie D. Expression of HERV-K proviruses in human leukocytes. Blood 81 (1993) 2369-2374
9. Brudek T., Lühdorf P., Christensen T., Hansen H.J., and Moller-Larsen A. Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV-6 and VZV. J. Neuroimmunol. 187 (2007) 147-155
10. Buzdin A., Kovalskaya-Alexandrova E., Gogvadse E., and Sverdlov E. At least 50% of human-specific HERV-K(HML-2) long terminal repeats serve in vivo as active promoters for host nonrepetitive DNA transcription. J. Virol. 80 (2006) 10752-10762
11. Cam H.P., Noma K.-I., Ebina H., Levin H.L., and Grewal S.I.S. Host genome surveillance for retrotransposons by transposon-derived proteins. Nature 451 (2008) 431-436
12. Chomczynski P., and Sacchi N. Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
13. Cohen M., Powers M., O'Connell C., and Kato N. Nucleotide sequence of the env gene from the human provirus ERV3 and isolation and characterization of an ERV3-specific cDNA. Virology 147 (1985) 449-458
14. Deininger P.L., and Batzer M.A. Mammalian retroelements. Genome Res. 12 (2002) 1455-1465
15. Deininger P.L., Moran J.V., Batzer M.A., and Kazazian Jr. H.H. Mobile elements and mammalian genome evolution. Current Opin. Genetics & Develop. 13 (2003) 651-658
16. Depil S., Roche C., Dussart P., and Prin L. Expression of a human endogenous retrovirus, HERV-K in the blood cells of leukemia patients. Leukemia 16 (2002) 254-259
17. Dewannieux M., Blaise S., and Heidmann T. Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses. J. Virol. 79 (2005) 15573-15577
18. Dewannieux M., Harper F., Richaud A., Letzelter C., Ribet D., Pierron G., and Heidmann T. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res. 16 (2006) 1548-1556
19. Dunn C.A., Romanish M.T., Gutierrez L.E., van de Lagemaat L.N., and Mager D.L. Transcription of two human genes from a bidirectional endogenous retrovirus promoter. Gene 366 (2006) 335-342
20. Fonatsch C., Nowotny H., Pittermann-Höcker E., Streubel B., Jäger U., Valent P., Büchner T., and Lechner K. Amplification of ribosomal RNA genes in acute myeloid leukemia. Genes Chrom. Cancer 32 (2001) 11-17
21. Frank O., Verbeke C., Schwarz N., Mayer J., Fabarius A., Hehlmann R., Leib-Mösch C., and Seifarth W. Variable transcriptional activity of endogenous retrovirus in human breast cancer. J. Virol. 82 (2008) 1808-1818
22. Heilbronn R., and zur Hausen H. A subset of herpes simplex virus replication genes induces DNA amplification within the host cell genome. J. Virol. 63 (1989) 3683-3692
23. Hsiao F.C., Lin M., Tai A., Chen G., and Huber B.T. Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells. J. Immunol. 177 (2006) 2056-2060
24. Hughes J.F., and Coffin J.M. Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution. Nature Gen. 29 (2001) 487-489
25. Hughes J.F., and Coffin J.M. Human endogenous retrovirus K solo-LTR formation and insertional polymorphisms: implications for human and viral evolution. Proc. Natl. Acad. Sci. USA 101 (2004) 1668-1672
26. Jern P., Sperber G.O., Ahlsen G., and Blomberg J. Sequence variability, gene structure and expression of full-length human endogenous retrovirus H. J. Virol. 79 (2005) 6325-6337
27. Kataoka K., and Huh N.H. A novel beta1,3-N-acetylglucosaminyltransferase involved in invasion of cancer cells as assayed in vitro. Biochem. Biophys. Res. Commun. 294 (2002) 843-848
28. Kitamura M., Maruyama N., Shirasawa T., Nagasawa R., Watanabe K., Tateno M., and Yoshiki T. Expression of an endogenous retroviral gene product in human placenta. Int. J. Cancer 58 (1994) 836-840
29. Kjellman C., Sjögren H.O., Salford L.G., and Widegren B. HERV-F (XA34) is a full-length human endogenous retrovirus expressed in placental and fetal tissues. Gene 239 (1999) 99-107
30. Landry J.R., and Mager D.L. Functional analysis of the endogenous retroviral promoter of the human endothelin B receptor gene. J. Virol. 77 (2003) 7459-7466
31. Landry J.R., Rouhi A., Medstrand P., and Mager D.L. The opitz syndrome gene mid1 is transcribed from a human endogenous retroviral promoter. Mol. Biol. Evol. 19 (2002) 1934-1942
32. Lee Y.N., and Bieniasz P.D. Reconstitution of an infectious human endogenous retrovirus. PLos Pathog. 3 (2007) e10
33. Leppik L., Gunst K., Lehtinen M., Dillner J., Streker K., and de Villiers E.-M. In vivo and in vitro intragenomic rearrangement of TT viruses. J. Virol. 81 (2007) 9346-9356
34. Lindeskog M., Mager D.L., and Blomberg J. Isolation of a human endogenous retroviral HERV-H element with an open env reading frame. Virology 258 (1999) 441-450
35. Lindeskog M., Medstrand P., Cunningham A.A., and Blomberg J. Coamplification and dispersion of adjacent human endogenous retroviral HERV-H and HERV-E elements; prescence of spliced hybrid transcripts in normal leukocytes. Virology 244 (1998) 219-229
36. Lou Z., Kastury K., Crilley P., Lasota J., Druck T., Croce C.M., and Huebner K. Characterization of human bone marrow-derived closed circular DNA clones. Genes Chrom. Cancer 7 (1993) 15-27
37. Löwer R., Boller K., Hasenmaier B., Korbmacher C., Müller-Lantzsch N., Löwer J., and Kurth R. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc. Natl. Acad. Sci. USA 90 (1993) 4480-4484
38. Maksakova I.A., and Mager D.L. Transcriptional regulation of early transposon elements, an active family of mouse long terminal repeat retrotransposons. J. Virol. 79 (2005) 13865-13874
39. Mameli G., Astone V., Khalili K., Serra C., Sawaya B.E., and Dolei A. Regulation of the syncytin-1 promoter in human astrocytes by multiple sclerosis-related cytokines. Virology 362 (2007) 120-130
40. Mayer J., Sauter M., Rácz A., Scherer D., Mueller-Lantzsch N., and Meese E. An almost intact human endogenous retrovirus K on human chromosome 7. Nature Gen. 21 (1999) 257-258
41. Medstrand P., Landry J.R., and Mager D.L. Long terminal repeats are used as alternative promoters for the endothelin B receptor and apolipoprotein C-I genes in humans. J. Biol. Chem. 276 (2001) 1896-1903
42. Medstrand P., Lindeskog M., and Blomberg J. Expression of human endogenous retroviral sequences in peripheral blood mononuclear cells of healthy individuals. J. Gen. Virol. 73 (1992) 2463-2466
43. Ogasawara H., Naito T., Kaneko H., Hishikawa T., Sekigawa I., Hashimoto H., Kaneko Y., Yamamoto N., Maruyama N., and Yamamoto N. Quantitative analyses of messenger RNA of human endogenous retrovirus in patients with systemic lupus erythematosus. J. Rheumatol. 28 (2001) 533-538
44. Oja M., Peltonen J., Blomberg J., and Kaski S. Methods for estimating human endogenous retrovirus activities from EST databases. BMC Bioinformatics 8 suppl 2 (2007) S11
45. Oricchio E., Sciamanna I., Beraldi R., Tolstonog G.V., Schumann G.G., and Spadafora C. Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene 26 (2007) 4226-4233
46. Patzke S., Lindeskog M., Munthe E., and Aasheim H.C. Characterization of a novel human endogenous retrovirus, HERV-H/F, expressed in human leukemia cell lines. Virology 303 (2002) 164-173
47. Renaudineau Y., Vallet S., Le Dantec C., Hillion S., Saraux A., and Youinou P. Characterization of the human CD5 endogenous retrovirus-E in B lymphocytes. Genes Immun. 6 (2005) 663-671
48. Schlehofer J.R., Gissmann L., Matz B., and zur Hausen H. Herpes simplex virus-induced amplification of SV40 sequences in transformed Chinese hamster embryo cells. Int. J. Cancer 32 (1983) 99-103
49. Schulte A.M., Malerczyk C., Cabal-Manzano R., Gajarsa J.J., List H.J., Riegel A.T., and Wellstein A. Influence of the human endogenous retrovirus-like element HERV-E-PTN on the expression of growth factor pleiotrophin: a critical role of a retroviral Sp1-binding site. Oncogene 19 (2000) 3988-3998
50. Senger M., Flores T., Glatting K., Ernst P., Hotz-Wagenblatt A., and Suhai S. W2H: WWW interface to the GCG sequence analysis package. Bioinformatics 14 (1998) 452-457
51. Shiroma T., Sugimoto J., Oda T., Jinno Y., and Kanaya F. Search for active endogenous retroviruses: identification and characterization of a HERV-E gene that is expressed in the pancreas and thyroid. J. Hum. Genet. 46 (2001) 619-625
52. Streubel B., Valent P., Jäger U., Edelhäuser M., Wandt H., Wagner T., Büchner T., Lechner K., and Fonatsch C. Amplification of the MLL gene on double minutes, a homogenously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome. Genes Chrom. Cancer 27 (2000) 380-386
53. Sutkowski N., Chen G., Calderon G., and Huber B.T. Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen. J. Virol. 78 (2004) 7852-7860
54. Takeuchi K., Katsumata K., Ikeda H., Minami M., Wakisaka A., and Yoshiki T. Expression of endogenous retroviruses ERV3 and lambda 4-1, in synovial tissues from patients with rheumatoid arthritis. Clin. Exp. Immunol. 99 (1995) 338-344
55. Taruscio D., Floridia G., Zoraqi G.K., Mantovani A., and Falbo V. Organization and integration sites in the human genome of endogenous retroviral sequences belonging to HERV-E family. Mammalian Genome 13 (2002) 216-222
56. Tönjes R.R., Czauderna F., and Kurth R. Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K. J. Virol. 73 (1999) 9187-9195
57. Villesen P., Aagaard L., Wiuf C., and Pedersen F.S. Identification of endogenous retroviral reading frames in the human genome. Retrovirology 1 (2004) 32-45
58. Wang-Johanning F., Liu J., Rycaj K., Huang K., Tsai K., Rosen D.G., Chen D.T., Lu D.W., Barnhart K.F., and Johanning G.L. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int. J. Cancer 120 (2007) 81-90
59. Wentzensen N., Coy J.F., Knaebel H.P., Linnebacher M., Wilz B., Gebert J., and von Knebel Doeberitz M. Expression of an endogenous retroviral sequence from the HERV-H group in gastrointestinal cancers. Int. J. Cancer 121 (2007) 1417-1423
60. Yamura N., Iwase A., Suzuki K., Maruyama N., and Kira S. Alveolar macrophages produce the env protein of a human endogenous retrovirus, HERV-E 4-1, in a subgroup of interstitial lung diseases. Am. J. Respir. Cell Mol. Biol. 16 (1997) 429-437
61. Zatkova A., Ullmann R., Rouillard J.M., Lamb B.J., Kuick R., Hanash S.M., Schnittger S., Schoch C., Fonatsch C., and Wimmer K. Distinct sequences on 11q13.5 and 11q23-24 are frequently coamplified with MLL in complexly organized 11q amplicons in AML/MDS patients. Genes Chrom. Cancer 39 (2004) 263-276
62. zur Hausen H. Infections Causing Human Cancer (2006), Wiley-VCH Verlag, Weinheim